Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Leslie J. Browne | M | 74 |
Sevion Therapeutics, Inc.
 Sevion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sevion Therapeutics, Inc. operates as Biopharmaceutical Company. It discovers, develops and acquires product candidates for the treatment of cancer and immunological diseases. The company was founded on September 30, 1999 and is headquartered in San Diego, CA. | 4 years |
| David S. Rector | M | 76 |
Sevion Therapeutics, Inc.
Sevion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sevion Therapeutics, Inc. operates as Biopharmaceutical Company. It discovers, develops and acquires product candidates for the treatment of cancer and immunological diseases. The company was founded on September 30, 1999 and is headquartered in San Diego, CA. | 15 years |
| Christoph Ammann | M | 74 | - | |
| Vaughn V. Smider | M | 54 |
Sevion Therapeutics, Inc.
Sevion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sevion Therapeutics, Inc. operates as Biopharmaceutical Company. It discovers, develops and acquires product candidates for the treatment of cancer and immunological diseases. The company was founded on September 30, 1999 and is headquartered in San Diego, CA. | - |
| Harlan Waksal | M | 71 |
Sevion Therapeutics, Inc.
Sevion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sevion Therapeutics, Inc. operates as Biopharmaceutical Company. It discovers, develops and acquires product candidates for the treatment of cancer and immunological diseases. The company was founded on September 30, 1999 and is headquartered in San Diego, CA. | 8 years |
| Joel P. Brooks | M | 65 |
Sevion Therapeutics, Inc.
Sevion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sevion Therapeutics, Inc. operates as Biopharmaceutical Company. It discovers, develops and acquires product candidates for the treatment of cancer and immunological diseases. The company was founded on September 30, 1999 and is headquartered in San Diego, CA. | 14 years |
| Jack van Hulst | M | 85 |
Sevion Therapeutics, Inc.
Sevion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sevion Therapeutics, Inc. operates as Biopharmaceutical Company. It discovers, develops and acquires product candidates for the treatment of cancer and immunological diseases. The company was founded on September 30, 1999 and is headquartered in San Diego, CA. | 7 years |
| David Mathers | M | 59 | 24 years | |
| Aziz Rodni Daoud Syriani | M | 81 | 15 years | |
| Jonathan Bram | M | 58 |
Credit Suisse First Boston Corp.
| 14 years |
| Steven Katz | M | 76 |
Sevion Therapeutics, Inc.
Sevion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sevion Therapeutics, Inc. operates as Biopharmaceutical Company. It discovers, develops and acquires product candidates for the treatment of cancer and immunological diseases. The company was founded on September 30, 1999 and is headquartered in San Diego, CA. | 1 years |
| Warren John Isabelle | M | 71 |
Sevion Therapeutics, Inc.
Sevion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sevion Therapeutics, Inc. operates as Biopharmaceutical Company. It discovers, develops and acquires product candidates for the treatment of cancer and immunological diseases. The company was founded on September 30, 1999 and is headquartered in San Diego, CA. | 5 years |
| Thomas C. Quick | M | 68 |
Sevion Therapeutics, Inc.
Sevion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sevion Therapeutics, Inc. operates as Biopharmaceutical Company. It discovers, develops and acquires product candidates for the treatment of cancer and immunological diseases. The company was founded on September 30, 1999 and is headquartered in San Diego, CA. | 15 years |
| Phillip Frost | M | 87 |
Sevion Therapeutics, Inc.
Sevion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sevion Therapeutics, Inc. operates as Biopharmaceutical Company. It discovers, develops and acquires product candidates for the treatment of cancer and immunological diseases. The company was founded on September 30, 1999 and is headquartered in San Diego, CA. | - |
| Richard Thornburgh | M | 71 | - | |
| Richard S. Dondero | M | 74 |
Sevion Therapeutics, Inc.
Sevion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sevion Therapeutics, Inc. operates as Biopharmaceutical Company. It discovers, develops and acquires product candidates for the treatment of cancer and immunological diseases. The company was founded on September 30, 1999 and is headquartered in San Diego, CA. | 10 years |
| Peter Derendinger | M | 64 | 13 years | |
| John N. Braca | M | 65 |
Sevion Therapeutics, Inc.
Sevion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sevion Therapeutics, Inc. operates as Biopharmaceutical Company. It discovers, develops and acquires product candidates for the treatment of cancer and immunological diseases. The company was founded on September 30, 1999 and is headquartered in San Diego, CA. | - |
| Steven Rubin | M | 63 |
Sevion Therapeutics, Inc.
Sevion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sevion Therapeutics, Inc. operates as Biopharmaceutical Company. It discovers, develops and acquires product candidates for the treatment of cancer and immunological diseases. The company was founded on September 30, 1999 and is headquartered in San Diego, CA. | - |
| Peter Brabeck-Letmathe | M | 79 | 17 years | |
| Lisa Heller | F | - |
Credit Suisse First Boston Corp.
| 2 years |
| Timothy P. O'Hara | M | 60 | 30 years | |
| Christian Langaard | M | - | 6 years | |
| Michael Meier | M | - |
Credit Suisse AG (Private Banking)
 Credit Suisse AG (Private Banking) Investment ManagersFinance Credit Suisse AG (Private Banking) (CSPB) is the Zurich-based private banking division of Credit Suisse AG, itself a subsidiary of Credit Suisse Group AG (VX: CSGN) in Switzerland. Established in 1856, CSPB provides comprehensive advice and a range of investment products and services to private, corporate and institutional clients. The firm is a leading provider of innovative alternative investment products. Their wealth management solutions include tax planning, pension planning, life insurance solutions, wealth and inheritance advice, trusts and foundations. | 9 years |
| Michel Ruffieux | M | - | - | |
| James Louis Amine | M | 65 | 23 years | |
| Thomas Andrea Müller | M | 59 | 3 years | |
| Markus C. Egloff | M | 63 | 19 years | |
| Guy Lachappelle | M | 62 | 5 years | |
| Matt Gelber | M | - |
Credit Suisse First Boston Corp.
| 4 years |
| Dixon Yee | M | - |
Credit Suisse First Boston Corp.
| 3 years |
| Klaus Jenny | M | 82 | 26 years | |
| Fidelis M. Götz | M | 58 | - | |
| George Mattson | M | 58 |
Credit Suisse First Boston Corp.
| 1 years |
| Bernhard Hodler | M | 64 | 4 years | |
| Hiroki Miyazato | M | 59 | 1 years | |
| Stephen Parrish Jones | M | - |
Credit Suisse First Boston Corp.
| - |
| Kevin Covert | M | - | 1 years | |
| Michael Hartmeier | M | 61 |
Credit Suisse First Boston Corp.
| 5 years |
| Nigel Spray | M | - | 5 years | |
| Louis Iaconetti | M | - | 11 years | |
| Arjun Ananth | M | - | 5 years | |
| Jonathan Yellen | M | - | 10 years | |
| Boehning Reiner | M | - | 16 years | |
| Julia Goh | F | - | 11 years | |
| Gish Lori | F | - | 15 years | |
| Bob Diamond | M | - | 4 years | |
| Caitlin Long | F | 54 | 10 years | |
| Laurie Hawkes | F | 68 |
Credit Suisse First Boston Corp.
| 2 years |
| Steve Cheng | M | - | 20 years | |
| Oleg Gordienko | M | - | 3 years | |
| Lars Bespolka | M | 60 | - | |
| Georg Stillhart | M | - |
Credit Suisse AG (Private Banking)
Credit Suisse AG (Private Banking) Investment ManagersFinance Credit Suisse AG (Private Banking) (CSPB) is the Zurich-based private banking division of Credit Suisse AG, itself a subsidiary of Credit Suisse Group AG (VX: CSGN) in Switzerland. Established in 1856, CSPB provides comprehensive advice and a range of investment products and services to private, corporate and institutional clients. The firm is a leading provider of innovative alternative investment products. Their wealth management solutions include tax planning, pension planning, life insurance solutions, wealth and inheritance advice, trusts and foundations. | 23 years |
| Urs Buchmann | M | 67 | - | |
| Stuart Andrew Firth | M | 51 | 15 years | |
| Mark Finerman | M | 61 |
Credit Suisse First Boston Corp.
| 3 years |
| Catherine Dondzila | F | 61 |
Credit Suisse First Boston Corp.
| 1 years |
| John Coughlin | M | 55 |
Credit Suisse First Boston Corp.
| 2 years |
| Thomas Roland Meier | M | 61 | 5 years | |
| Marilyn Hirsch | F | 56 | 11 years | |
| Blake Burdine | M | 57 |
Credit Suisse First Boston Corp.
| 1 years |
| Mark C. Monaco | M | 58 |
Credit Suisse First Boston Corp.
| 5 years |
| Veit D. de Maddalena | M | 57 |
Credit Suisse AG (Private Banking)
Credit Suisse AG (Private Banking) Investment ManagersFinance Credit Suisse AG (Private Banking) (CSPB) is the Zurich-based private banking division of Credit Suisse AG, itself a subsidiary of Credit Suisse Group AG (VX: CSGN) in Switzerland. Established in 1856, CSPB provides comprehensive advice and a range of investment products and services to private, corporate and institutional clients. The firm is a leading provider of innovative alternative investment products. Their wealth management solutions include tax planning, pension planning, life insurance solutions, wealth and inheritance advice, trusts and foundations. | - |
| Marco Daescher | M | - | - | |
| Marc-Henri Beausire | M | 53 | 8 years | |
| Robert Diamond | M | 72 |
Credit Suisse First Boston Corp.
| 4 years |
| Markus K. Christen | M | - | 7 years | |
| Frederick W. Brazelton | M | 52 | 2 years | |
| Hans-Jörg Rudloff | M | 83 | - | |
| Thomas W. Bechtler | M | 75 | 15 years | |
| George Petros Molyviatis | M | 62 | 2 years | |
| José Ramón González | M | 69 |
Credit Suisse First Boston Corp.
| - |
| Eric J. Smith | M | 66 | 24 years | |
| James Joseph Graziano | M | 56 |
Sevion Therapeutics, Inc.
Sevion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sevion Therapeutics, Inc. operates as Biopharmaceutical Company. It discovers, develops and acquires product candidates for the treatment of cancer and immunological diseases. The company was founded on September 30, 1999 and is headquartered in San Diego, CA. | - |
| Lester Brafman | M | 61 |
Credit Suisse First Boston Corp.
| 6 years |
| Samuel Liss | M | 67 |
Credit Suisse First Boston Corp.
| 7 years |
| Bruce C. Galton | M | 72 |
Sevion Therapeutics, Inc.
Sevion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sevion Therapeutics, Inc. operates as Biopharmaceutical Company. It discovers, develops and acquires product candidates for the treatment of cancer and immunological diseases. The company was founded on September 30, 1999 and is headquartered in San Diego, CA. | 8 years |
| Sascha P. Fedyszyn | M | 49 |
Sevion Therapeutics, Inc.
Sevion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sevion Therapeutics, Inc. operates as Biopharmaceutical Company. It discovers, develops and acquires product candidates for the treatment of cancer and immunological diseases. The company was founded on September 30, 1999 and is headquartered in San Diego, CA. | 12 years |
| Herbert C. Williamson | M | 75 |
Credit Suisse First Boston Corp.
| 3 years |
| Tobias Guldimann | M | 62 | 28 years | |
| Chris Hentemann | M | - |
Credit Suisse First Boston Corp.
| - |
| Antonio Carlos Quintella | M | 58 | 15 years | |
| Alex Rushing | M | - |
Credit Suisse First Boston Corp.
| - |
| Alexandre Zeller | M | 63 | 15 years | |
| Peter Sami | M | 66 | - | |
| Rajiv K. Garg | M | 64 |
Credit Suisse First Boston Corp.
| 6 years |
| Miguel A. de los Ríos | M | 49 |
Sevion Therapeutics, Inc.
Sevion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sevion Therapeutics, Inc. operates as Biopharmaceutical Company. It discovers, develops and acquires product candidates for the treatment of cancer and immunological diseases. The company was founded on September 30, 1999 and is headquartered in San Diego, CA. | - |
| Eric Morris Varvel | M | - | - | |
| Julian Baker | M | 57 |
Credit Suisse First Boston Corp.
| 5 years |
| Donald Christopher Cacciapaglia | M | 73 | 1 years | |
| Michael Paravicini | M | 63 | 14 years | |
| Chrystal Y. Badillo | F | - |
Credit Suisse First Boston Corp.
| 4 years |
| Mark Warms | M | 61 | 6 years | |
| Andreas R. Spahni | M | 66 | 9 years | |
| Olivier Steimer | M | 68 | 5 years | |
| James R. Amoroso | M | - | 3 years | |
| Neil A. Richardson | M | 67 |
Credit Suisse First Boston Corp.
| 8 years |
| Alex Rosen | M | - | 3 years | |
| Rémy A. Bersier | M | 67 | - | |
| Joshua Tanzer | M | - |
Credit Suisse AG (Private Banking)
Credit Suisse AG (Private Banking) Investment ManagersFinance Credit Suisse AG (Private Banking) (CSPB) is the Zurich-based private banking division of Credit Suisse AG, itself a subsidiary of Credit Suisse Group AG (VX: CSGN) in Switzerland. Established in 1856, CSPB provides comprehensive advice and a range of investment products and services to private, corporate and institutional clients. The firm is a leading provider of innovative alternative investment products. Their wealth management solutions include tax planning, pension planning, life insurance solutions, wealth and inheritance advice, trusts and foundations. | 7 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Switzerland | 59 | 59.00% |
| United States | 41 | 41.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Rudolf Stalder
- Personal Network
